Denali Capital Acquisition (DECA)
Denali Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purch...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 11.430
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- 8.72M
- Market CapUSD
- 38.00M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.0316
- EPSDynamic
- -0.0316
- EPSStatic
- --
- BVPS
- -3.13
- P/B
- --
- Circulating Supply
- 763.04K
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 3.32M
- Min lot size
- 1
- Currency
- USD
News
- StockTitan · Sep 22, 2025 at 07:49 PM
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination | SCLX Stock News
- TradingView · Aug 15, 2025 at 11:53 AM
Denali Capital Acquisition Corp. SEC 10-Q Report
